Related Experiment Videos

Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear

W L Hand1, N King-Thompson, J W Holman

  • 1Veterans Administration Medical Center (Atlanta), Decatur, Georgia 30033.

Insights

Roxithromycin and trimethoprim show high uptake by human phagocytes (PMN). These antibiotics concentrate well within cells, suggesting potential for treating intracellular infections.

Area of Science:

  • Pharmacology
  • Immunology
  • Microbiology

Background:

  • Antibiotic entry into phagocytes is crucial for combating intracellular pathogens.
  • Understanding antibiotic accumulation in human polymorphonuclear leukocytes (PMN) is key for effective treatment strategies.

Purpose of the Study:

  • To evaluate the uptake of five newer antibiotics by human PMN.
  • To identify antibiotics with significant intracellular accumulation for potential use against intracellular infections.

Main Methods:

  • Utilized velocity gradient centrifugation to measure antibiotic uptake by PMN.
  • Expressed uptake as the cellular to extracellular concentration ratio (C/E).
  • Investigated roxithromycin uptake kinetics and the effect of particle ingestion.

Main Results:

  • Roxithromycin demonstrated the highest PMN concentration (C/E = 34), indicating active, carrier-mediated transport.
  • Trimethoprim also showed significant PMN accumulation (C/E = 9-13), with higher uptake at 25°C than 37°C.
  • Cefotaxime and metronidazole had poor to moderate PMN uptake, while imipenem showed rapid binding but declining levels.

Conclusions:

  • Roxithromycin and trimethoprim are markedly concentrated within human PMN.
  • These findings highlight the potential therapeutic value of roxithromycin and trimethoprim for infections caused by intracellular organisms.

Related Concept Videos